MedPath

The effect of clinical characterization of children with bedwetting on the efficacy of therapy.

Phase 1
Conditions
Enuresis nocturna
Therapeutic area: Not possible to specify
Registration Number
EUCTR2017-002169-23-BE
Lead Sponsor
Aarhus University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
400
Inclusion Criteria

1. Age 6-14 years.
2. Three or more wet nights per week regarding the home registrations.
Are the trial subjects under 18? yes
Number of subjects for this age range: 400
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

1. Ongoing constipation and/or faecal incontinence.
2. Daytime symptoms such as urgency, frequency or incontinence.
3. Recurrent urinary tract infections.
4. Anamnestic, clinical or laboratory findings that can be related to diseases or conditions that might affect the parameters investigated.
5. Neurological and/or known clinically significant anatomical abnormalities of the urinary tract.
6. Former operations in the urinary tract.
7. Prior or ongoing treatment with alarm, desmopressin or anticholinergics.
8. Ongoing medication that may interfere with the parameters tested.
9. Pregnant or lactating girl.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath